Caroline J Bull

Caroline J Bull

University of Bristol

H-index: 12

Europe-United Kingdom

About Caroline J Bull

Caroline J Bull, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Bristol,

His recent articles reflect a diverse array of research interests and contributions to the field:

The association between body mass index and metabolite response to a liquid mixed meal challenge: a Mendelian randomization study

A genome-wide association study of neutrophil count in individuals associated to an African continental ancestry group facilitates studies of malaria pathogenesis

Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease

Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes

Identifying metabolic features of colorectal cancer liability using Mendelian randomization

The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)

Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study

Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study

Caroline J Bull Information

University

Position

___

Citations(all)

710

Citations(since 2020)

674

Cited By

135

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

13

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Top articles of Caroline J Bull

The association between body mass index and metabolite response to a liquid mixed meal challenge: a Mendelian randomization study

medRxiv

2023

A genome-wide association study of neutrophil count in individuals associated to an African continental ancestry group facilitates studies of malaria pathogenesis

Human Genomics

2024/3/15

Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease

Scientific Reports

2024/2/16

Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes

EBioMedicine

2024/2/1

Identifying metabolic features of colorectal cancer liability using Mendelian randomization

Elife

2023/12/21

The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)

Diabetologia

2024/1

Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study

International Journal of Cancer

2024/1/1

Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study

EBioMedicine

2023/4/1

Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study

BMC medicine

2023/1/4

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study

PLoS Medicine

2023/1/3

Investigating a causal role for neutrophil count on P. falciparum severe malaria: a Mendelian Randomization study

medRxiv

2023

A phenome-wide approach to identify causal risk factors for deep vein thrombosis

BMC Medical Genomics

2023/11/11

Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization

Elife

2023/4/12

Genetically-proxied anti-diabetic drug target perturbation and risk of cancer: a Mendelian randomization analysis

medRxiv

2022/10/26

The effect of metabolic traits on oral and oropharyngeal cancer risk: a Mendelian randomization analysis

medRxiv

2022/8/10

The metabolomic signature of weight loss in the Diabetes Remission Clinical Trial (DiRECT)

medRxiv

2022/7/17

Correction: Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation

Elife

2022/5/18

Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis

JNCI: Journal of the National Cancer Institute

2022/5/1

Genetically proxied PCSK9 inhibition provides indication of lower prostate cancer risk: A Mendelian randomization study

medRxiv

2022/4/19

See List of Professors in Caroline J Bull University(University of Bristol)